SCHEMBL19984639

SCHEMBL19984639

O=C1CC2CCCCN2c2ccc(C(=O)O)cc2N1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.48
ALOX15 P16050 1/20 0.48
L3MBTL1 Q9Y468 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
PABPC1 P11940 1/20 0.43
GAA P10253 4/20 0.42
PARP1 P09874 3/20 0.42
KDM4E B2RXH2 4/20 0.42
POLB P06746 3/20 0.42
HTT P42858 1/20 0.41
SMYD3 Q9H7B4 3/20 0.40
HTR2C P28335 1/20 0.39
TSHR P16473 1/20 0.39
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HPGD P15428 1/20 0.39
NR4A1 P22736 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19984708 0.86 HSD17B10 (0.67) HSD17B10ALOX15L3MBTL1MEN1KMT2A
SCHEMBL2505469 0.82 HSD17B10 (0.69) HSD17B10ALOX15L3MBTL1MEN1KMT2A
SCHEMBL17748861 0.73 GAA (0.64) MEN1KMT2AGAAKDM4EHTR2C
SCHEMBL19984748 0.73 SMYD3 (0.41) MEN1KMT2ASMYD3
SCHEMBL3629129 0.72 HTR2C (0.44) MEN1KMT2APOLBHTTHTR2C
SCHEMBL2507969 0.69 HSD17B10 (0.93) HSD17B10ALOX15L3MBTL1MEN1KMT2A
SCHEMBL10761357 0.69 MAPT (0.44) HSD17B10L3MBTL1MEN1KMT2AGAA
SCHEMBL25974508 0.69 MAPT (0.44) HSD17B10L3MBTL1MEN1KMT2AGAA
SCHEMBL31436228 0.69 MAPT (0.44) HSD17B10L3MBTL1MEN1KMT2AGAA
SCHEMBL845758 0.69 KDM4E (0.46) HSD17B10L3MBTL1TDP1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2022-01-27 US disclosed
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2022-01-27 US disclosed
US-10987360-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2021-04-27 US disclosed
US-10987360-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2021-04-27 US disclosed
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2019-08-22 US disclosed
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2019-08-22 US disclosed
WO-2018053157-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10987360-B2 Hepatitis B core protein modulators HAVCR2, FABP1, MAVS HSD17B10 1394/4885ALOX15 3298/4885L3MBTL1 2994/4885
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS HSD17B10 1394/4885ALOX15 3298/4885L3MBTL1 2994/4885
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS HSD17B10 1394/4885ALOX15 3298/4885L3MBTL1 2994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.